Intrathecal minocycline suppresses itch-related behavior and improves dermatitis in atopic dermatitis model mouse.
Intrathecal minocycline suppresses itch-related behavior and improves dermatitis in atopic dermatitis model mouse.
复制标题
鞘内注射米诺环素可抑制特应性皮炎模型小鼠的瘙痒相关行为并改善皮炎。
DOI:
10.1016/j.jid.2015.12.037
复制
发表时间:
2016
影响因子:
6.5
通讯作者:
Takamori K.
中科院分区:
文献类型:
--
作者:
Torigoe K;Tominaga M;Ko KC;Takahashi N;Matsuda H;Hayashi R;Ogawa H; Takamori K.
Chronic and intractable itch may occur due to abnormal neuronal firing in both the peripheral and central nervous systems. Recently, it has been demonstrated that spinal glial cells, such as microglia and astrocytes, are involved in modulation of neuropathic pain. However, the roles of spinal glial cells in intractable itch of skin diseases, such as atopic dermatitis (AD), are currently unknown. This study was performed to examine the antipruritic effects of lumbar intrathecal administration of minocycline, an inhibitor of microglial activation, in NC/Nga mice, AD-like model. Dermatitis was induced in mice by repeated application of Dermatophagoides farinae body (Dfb), and numbers of scratching bouts and spinal Iba1-immunoreactive (Iba1+) microglia were increased in the Dfb-NC/Nga mice compared with those in control mice. In pharmacological experiments, intrathecal minocycline dose-dependently reduced scratching bouts, concomitant with decreased number of spinal Iba1+ microglia in the Dfb-NC/Nga mice. Intrathecal minocycline also improved the dermatitis and skin barrier function in the Dfb-NC/Nga mice. Additionally, Oral administration of high-dose minocycline improved dermatitis and showed a tendency to reduce the numbers of scratching bouts and spinal Iba1+ microglia in the Dfb-NC/Nga mice. Therefore, spinal microglia may be one of the therapeutic targets for the intractable itch associated with AD.